Mictonorm

Propiverine Hydrochloride, the active ingredient in Mictonorm, is an antimuscarinic presented as an oral tablet for oral use. It is indicated for the management of overactive bladder symptoms, including urgency, frequency, and urge incontinence, in adult patients. It is marketed within the European Union and is available by prescription only.

GNH USA supplies Mictonorm as a licensed, GDP‑compliant international pharmaceutical supplier, adhering to stringent quality standards and regulatory requirements. The company provides the product to hospitals, pharmacies and clinics worldwide, supporting global access to reliable overactive bladder therapy.

Propiverine Hydrochloride is used to treat disorders of bladder storage associated with overactive bladder. - Overactive bladder: reduces urgency, frequency and episodes of urge incontinence. - Urinary urgency: diminishes the sudden need to void. - Urinary frequency: lowers the number of daily voids. - Urge urinary incontinence: helps prevent involuntary leakage.

Propiverine Hydrochloride may be associated with several adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Dry mouth: sensation of oral dryness. - Constipation: reduced bowel movements. - Blurred vision: temporary visual disturbance. - Headache: mild to moderate head pain. - Dizziness: feeling of light‑headedness.

Serious or Rare Side Effects: - Severe allergic reaction: rash, swelling, or anaphylaxis. - Acute urinary retention: inability to void requiring catheterisation. - Tachycardia: rapid heart rate. - Angle‑closure glaucoma: eye pain with visual changes. - Hepatic dysfunction: abnormal liver enzymes or jaundice.

When prescribing Propiverine Hydrochloride, clinicians should consider several precautionary measures. - Assess renal function: adjust use if severe impairment is present. - Monitor for urinary retention: especially in patients with bladder outlet obstruction. - Avoid in uncontrolled narrow‑angle glaucoma: anticholinergic effect may worsen condition. - Use caution in the elderly: higher susceptibility to anticholinergic adverse effects. - Pregnancy and lactation: safety not established; weigh benefits against potential risks. - Store at ambient temperature: keep in the original pack, protect from moisture and light.

Propiverine Hydrochloride can interact with other medicines; awareness of interaction severity guides clinical decisions.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin): may increase propiverine plasma concentrations. - Other anticholinergic agents (e.g., antihistamines, tricyclic antidepressants): additive anticholinergic burden. - Medications that predispose to urinary retention (e.g., high‑dose alpha‑blockers): heightened risk of retention.

Moderate Interactions (Monitor Closely): - CYP3A4 inducers (e.g., rifampicin, carbamazepine): may reduce therapeutic effect. - Diuretics: altered bladder filling dynamics may affect symptom control. - Concomitant bladder antimuscarinics: potential for cumulative side effects.